- Ablation
- Abnormal
- Abraxane
- Acral melanoma
- ALK1
- Acute
- Adenocarcinoma
- Adenoma
- Adjuvant
- Adjuvant
- Advanced Disease
- Adverse Effect, Side Effect
- Afinitor
- Alimta
- Alopecia
- Analgestic
- Anaplasia (Anaplastic)
- Anaplastic astrocytoma
- Androgen
- Anemia
- Anesthetic
- Angiogenesis
- Anti
- Anti Androgen Treatment
- Anti Angiogenesis
- Antibody
- Anticoagulant
- Antigen
- Antioxidant
- Arimidex
- Aromatase
- Aromatase Inhibitors
- Astrocytoma
- athology Report
- Avastin
- Axilla
- Axillary dissection
- Basal cell carcinoma
- BCOR
- Benign
- Bilateral cancer
- Bilirubin
- Biologics
- Biomarker
- Biopsy
- Biosimilar
- Blood-brain barrier (BBB)
- Bolus
- Bone Marrow
- Bone Marrow Biopsy
- Bone Marrow Transplantation
- Bone Scan
- Brachytherapy
- BRAF
- BRCA1
- BRCA1, BRCA2
- BRCA1
- Colon Cancer
- Breast Cancer
- Breast cancer ages
- Breast Cancer in Men
- Breast-conserving Surgery (Lumpectomy)
- CA-125
- CA 125
- Camptosar
- Cancer
- Cancer of Unknown Primary – CUP
- Cannabinoids
- Cannabis
- Capecitabine
- CAR-T
- Carboplatin
- Carcinoembryonic Antigen
- Carcinogen
- Carcinoma
- Carcinoma In-situ
- Cardial
- Cardiotoxicity
- Case report
- Cerebral Spinal Fluid, CSF
- Cerebral Spinal Fluid, CSF
- Cervical cancer
- Chemoradiotherapy
- Chemotherapy
- Cisplatin
- Clinical Trials
- Clinical trial
- CNS HGNET-BCOR
- Colonoscopy
- Colorectal Cancer
- Colostomy
- Colostomy
- Combination therapy
- Comorbidity
- Compassionate Drug
- Compassionate drugs
- Compassionate use
- Complementary Medicine
- Complete Response
- Continuous infusion
- Control group
- Controlled Clinical Trial
- COX-2 Inhibitors
- Creatinine
- CT
- CTLA-4
- Cyramza
- cystoscopy
- Cytokine
- Cytokine
- Cytology
- Cytostatic medications
- Cytotoxic
- Cytotoxic T lymphocyte antigen 4
- CTLA-4
- Debuking
- DIPG
- DNA
- Docetaxel
- Docetaxel Ebewe
- Docetaxel Hospira
- Doxorubicin
- Ductal Carcinoma
- Ductal Carcinoma In-Situ, DCIS
- Ductal Carcinoma In-Situ, DCIS
- Dysplasia
- Edema
- Eloxatin
- Emesis
- Endocrine Therapy
- Endocrine Therapy
- ERCP
- Endoscopy
- Enteral
- Epidemiology
- Epidermal Growth Factor Receptor
- EGFR
- Epithelial Ovarian Cancer
- Epithelial Overian Carcinoma
- Epithelium (epithelial cells)
- ERBB2, HER2, HER-2
- ERCP
- Erivedge
- Erythrocyte
- ESR
- erythropoietin
- ESMO
- Esophagectomy
- Esophagus
- ESR
- Estrogen
- Estrogen Receptor Negative, ER+
- Estrogen Receptor Positive, ER+
- Estrogen Receptor Test
- Estrogen Replacement Therapy, ERT
- Estrogen Replacement Therapy, ERT
- etoposide
- Exemasin
- External Beam Radiation, EBT
- False Positive
- Familial Adenomatous Polyposis, FAP
- Familial Cancer
- Faslodex
- Fatigue
- FDA - Food and Drug Administration
- Fecal Occult Blood Test, FOBT
- Femara
- Fine Needle Aspiration
- First Line treatment
- Fluorouracil
- Folate, Folic Acid
- Food and Drug Administration
- Food and Drug Administration, FDA
- Free Radical
- Frozen Section Biopsy
- Gardasil
- Gastrectomy
- Gastric cancer
- Gastro-intestinal Stromal Tumor, GIST
- Gastroenterology
- Gastroscopy
- gemcitabine
- Gemzar
- Gene
- Generic
- Genetic Counselor
- Genetic Testing
- Genome
- Germ Cell ovarian cancer
- Gliadel®
- GBM
- Glioblastoma
- Glioma
- Granulocyte-colony stimulating factor , G-CSF, GCSF
- Growth Hormone
- Hand and foot syndrome(HFS)
- Head and Neck Cancer
- Hematopoiesis
- Hemoglobin
- Heparin
- Hepatitis
- Hepatobiliary
- HER2 positive Breast Cancer
- Herceptin
- Hodgkin lymphoma
- Hormonal Therapy, Hormone Treatment
- Hormonal Therapy, Hormone Treatment
- Hormone
- Hormone positive breast cancer
- Hormone replacement therapy, HRT
- hormone replacement therapy, HRT
- HER2
- Hycamtin
- Hyperalimentation,Total Parenteral Nutrition, TPN
- Hypernephroma
- Hyperplasia
- Hyperthermic Intraperitoneal Chemotherapy, HIPEC
- Hysterectomy
- Hysterectomy
- Ibrance
- Idiopathic
- Imaging
- Immunosuppressive barrier
- Immune Check Points inhibitors
- Immune Response
- Immune System
- Immunotherapy
- in-situ
- Indolent
- Induction
- Infection
- Inflammation
- Inflammatory breast cancer
- Infusion
- Interferon
- Interleukin (IL)
- Intermittent Infusion
- Intracavitary Radiation Therapy
- Intracavitary Radiation Therapy
- Invasive Cancer Infiltrating Cancer
- Camptosar
- Irreversible Toxicity
- Jaundice
- Kadcyla
- Karnofsky Performance Status, KPS
- Keytruda
- Keytruda
- Keytruda® Price
- Keytruda side effects
- Kisqali
- Laparoscope
- Laparoscopy
- Leptomeningeal Cancer
- Leptomeningeal metastase, LM
- letrozole
- Leucovorin
- leukemia
- Leukocyte
- leukopenia
- LHRH Agonist
- Libtayo
- liposarcoma
- Lobectomy
- Lobular Carcinoma In-Situ, LCIS
- Local Cancer
- Local Treatment
- Locally Advanced Cancer
- Lower GI Series
- Lucrin
- Lumbar Puncture, Spinal Tap
- Lumpectomy
- Lymph Node
- Lymph Node
- Lymph Node Dissection
- lymph node mapping
- lymphadenectomy
- Lymphatic Dissection
- Lymphatic System
- Lymphedema
- lymphedema
- Lymphocyte
- Lymphoma
- Lynparza
- Magnetic resonance imaging
- MRI
- Maintenance Therapy
- Malignant
- Mammography
- Margin (Surgical Margin)
- Mastectomy
- Median Survival
- Median Survival
- Mediastinoscopy
- Mekinist
- Melanoma
- Menopause
- Mesothelioma
- Metastasectomy
- Metastasis
- Metastatic Cancer
- Metastatic melanoma
- Micro Satellite Instability, MSI
- Micrometastasis
- Micrometastasis
- Microsatellite Stable, MSS
- Morbidity
- Morphin
- MRI
- MUC1
- Multikinase inhibitor
- Mutation
- Myalgia
- Myelome
- Navelbine
- NCI
- Neck Dissection
- Negative Margin
- Neoadjuvant
- Neoadjuvant
- Neoplasm
- Neuroblastoma
- Node
- Node-Negative
- Node-Positive
- Non-Hodgkin Lymphoma
- Non Small Cell Lung Cancer
- NSCLC
- Objective Response
- Odomzo
- Oncogene
- Oncologist
- Oncology
- Optune
- osteolytic metastases
- Osteosarcoma
- Outpatient
- Bladder Cancer
- Overall Survival (OS)
- Overexpression
- Oxaliplatin
- Palliative
- Palliative care treatment
- Pancreas head
- Pancreatic cancer
- Pancreatic cancer
- Pancreatic cancer symptoms
- Pap test
- Papilloma Virus
- Parenteral
- Partial Response
- Pathological Fracture
- Pathologist
- PD-1
- PD-L1
- Pelvic Exenteration
- Peritoneal Cancer
- Peritoneum
- Peritoneum
- Perjeta
- PET
- PET CT
- Pharmacogenetics
- Pharmacology
- Placebo
- Platelets
- Pleural Effusion
- Poly ADP-ribose polymerase, PARP
- Polyp
- Polypectomy
- Positive Margins
- Positron Emission Tomography, PET
- Post menopause
- Postoperative
- Perimenopause
- Precision Medicine, Personalized Medicine
- Progesterion Receptor Test
- Progesteron
- Progesteron Receptor Negative, PR-
- Progesteron Receptor Positive, PR+
- Prognosis
- Progression Free Survival
- Prophylactic
- Prophylactic Mastectomy
- Prophylactic Oophorectomy
- Quality of Life, QOL
- Radical cystectomy
- Radical Hysterectomy
- Radical Hysterectomy
- Radical lymph node dissection
- Radical Mesectomy
- Radical Neck Dissection
- Radiotherapy
- Receptor
- Recurrent Cancer
- Recurrent Cancer, Relapse
- Red Blood Cell, RBC
- Refractory
- Remission
- Remission
- Resectable
- Residual
- Resilience, Resistance
- Response Rate
- Retrospective Study
- Rhabdomyoscoma
- ROS1
- Ewing's sarcoma
- Screening
- Screening
- Screening Mammogram
- Second Line Treatment
- Second primary cancer
- Secondary Cancer
- Sedimentation rate
- Senital Node
- Senital Node Test
- Sentinel lymph node
- Sentinel Lymph Node Biopsy
- Skin Cancer
- Skin Cancer Squamous Cell Carcinoma
- Small cell carcinoma of the ovary
- Small Cell Lung Cancer, SCLC
- Solid Tumors
- somatotropin
- Sorafenib
- Squamous Cell Carcinoma
- Squamous Cell Sarcinoma
- Stable Disease
- Stage 4
- Stage IV
- Stage/Staging
- Standard Of Care
- Statistically significant
- Stoma
- Stromal cell ovarian cancer
- Suppressor
- Survival Rate
- Symptom
- Systemic
- Systemic Treatment
- Tafinlar
- Tamoxifen
- Erlotinib
- Tarceva
- Targeted Therapy
- Taxotere
- TEMODAR®
- Teratogen
- Therapeutic Index
- Third Line Treatment
- Thrombocyt
- Thrombocytopenia
- Thrombosis
- Tomogrophy
- Tomogrophy
- Transformation
- Transrectal endoscopic ultrasound, TRUS
- Triple Negative
- Triple positive breast cancer
- True positive
- Tube Enteral Feeding
- Tumor
- Marker
- Tumor Suppressor Gene
- Tykerb
- Tyrosine Kinase
- Ultrasound
- Upper GI endoscopy
- Venous thrombosis, VT
- Verzenio
- Vinorelbin "Ebewe"
- Vinorelbine
- Whipple procedure pancreaticoduodenectomy
- White Blood Cell
- Whole Blood Count
- Xeloda
- Yervoy
- Zelboraf
- Zoladex
- Generic Drug
- Opdivo
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp
Cancer Glossary
To get a personal free assessment to our service please in fill in your details and we will get back to you shortly
Improve therapeutic outcomes, prolong life and quality of life are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.
Article categories
קטגוריות המאמרים
Popular topics
